Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Learn ways to align every expenditure with your financial goals. Prioritize essential spending, reduce waste, and monitor goal progress.
23,330 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
As AMD gears up for its July 22 AI event, traders are weighing the risk and reward. This article outlines why the set...
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
US search interest in Bitcoin has surged to a five-year high even as prices remain in a bear market. Traders watch wh...
As the Q4 2025 earnings season unfolds, savvy investors turn to transcripts to separate sound bites from real signal....
When AI generated war videos appear without disclosure, monetization can vanish. This piece explains what Xs warning ...
Top U.S. homebuilders are backing Avila Real Estate Capital’s AREC Fund II, signaling a shift in housing finance as b...
Solana climbs toward the $100 threshold as institutional ETF demand and rising open interest boost the token’s moment...
Federal health officials issued a warning about misleading statements from biotech billionaire Patrick Soon-Shiong re...
INDA still leads India ETF liquidity, but two rivals, EPI and IND, are drawing attention for their unique screens and...
As Stanford’s AI Index shows lagging adoption in the U.S., analysts say the real payoff comes from integration and tr...
Wix faced a sharp stock drop after its quarterly results and cautious analyst notes. This article breaks down the fac...